AEHR vs. TRNS, CTKB, LAB, EYPT, SENS, ALNT, QTRX, QSI, NAUT, and KEQU
Should you be buying Aehr Test Systems stock or one of its competitors? The main competitors of Aehr Test Systems include Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Senseonics (SENS), Allient (ALNT), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), and Kewaunee Scientific (KEQU). These companies are all part of the "measuring and control equipment" industry.
Aehr Test Systems vs.
Transcat (NASDAQ:TRNS) and Aehr Test Systems (NASDAQ:AEHR) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.
Aehr Test Systems has a net margin of 49.63% compared to Transcat's net margin of 6.63%. Aehr Test Systems' return on equity of 29.31% beat Transcat's return on equity.
In the previous week, Aehr Test Systems had 33 more articles in the media than Transcat. MarketBeat recorded 37 mentions for Aehr Test Systems and 4 mentions for Transcat. Transcat's average media sentiment score of 0.44 beat Aehr Test Systems' score of 0.07 indicating that Transcat is being referred to more favorably in the media.
Transcat currently has a consensus price target of $130.25, indicating a potential upside of 29.81%. Aehr Test Systems has a consensus price target of $25.00, indicating a potential upside of 100.64%. Given Aehr Test Systems' higher possible upside, analysts plainly believe Aehr Test Systems is more favorable than Transcat.
Transcat received 78 more outperform votes than Aehr Test Systems when rated by MarketBeat users. Likewise, 66.88% of users gave Transcat an outperform vote while only 58.41% of users gave Aehr Test Systems an outperform vote.
Aehr Test Systems has lower revenue, but higher earnings than Transcat. Aehr Test Systems is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
98.3% of Transcat shares are owned by institutional investors. Comparatively, 69.7% of Aehr Test Systems shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 6.2% of Aehr Test Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Transcat has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, Aehr Test Systems has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500.
Summary
Transcat and Aehr Test Systems tied by winning 9 of the 18 factors compared between the two stocks.
Get Aehr Test Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for AEHR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aehr Test Systems Competitors List
Related Companies and Tools
This page (NASDAQ:AEHR) was last updated on 1/21/2025 by MarketBeat.com Staff
